Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease

Identifieur interne : 000912 ( PascalFrancis/Corpus ); précédent : 000911; suivant : 000913

Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease

Auteurs : Susanne M. Morton ; Ya-Weng Tseng ; Kathleen M. Zackowski ; Jaclyn R. Daline ; Amy J. Bastian

Source :

RBID : Pascal:10-0446321

Descripteurs français

English descriptors

Abstract

Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 25
A06       @2 12
A08 01  1  ENG  @1 Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease
A11 01  1    @1 MORTON (Susanne M.)
A11 02  1    @1 TSENG (Ya-Weng)
A11 03  1    @1 ZACKOWSKI (Kathleen M.)
A11 04  1    @1 DALINE (Jaclyn R.)
A11 05  1    @1 BASTIAN (Amy J.)
A14 01      @1 Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine @2 Iowa City, Iowa @3 USA @Z 1 aut.
A14 02      @1 Department of Physical Therapy, Temple University @2 Philadelphia, Pennsylvania @3 USA @Z 2 aut.
A14 03      @1 Kennedy Krieger Institute @2 Baltimore, Maryland @3 USA @Z 3 aut. @Z 5 aut.
A14 04      @1 Department of Neurology, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 3 aut. @Z 5 aut.
A14 05      @1 Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine @2 Baltimore, Maryland @3 USA @Z 3 aut. @Z 5 aut.
A14 06      @1 Program in Physical Therapy, Washington University School of Medicine @2 St. Louis, Missouri @3 USA @Z 4 aut.
A20       @1 1944-1952
A21       @1 2010
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000194841700240
A44       @0 0000 @1 © 2010 INIST-CNRS. All rights reserved.
A45       @0 36 ref.
A47 01  1    @0 10-0446321
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Pathologie du cervelet @5 01
C03 01  X  ENG  @0 Cerebellar disease @5 01
C03 01  X  SPA  @0 Cerebelar enfermedad @5 01
C03 02  X  FRE  @0 Ataxie @5 02
C03 02  X  ENG  @0 Ataxia @5 02
C03 02  X  SPA  @0 Ataxia @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Pistage @5 09
C03 04  X  ENG  @0 Tracking @5 09
C03 04  X  SPA  @0 Rastreo @5 09
C03 05  X  FRE  @0 Cervelet @5 10
C03 05  X  ENG  @0 Cerebellum @5 10
C03 05  X  SPA  @0 Cerebelo @5 10
C03 06  X  FRE  @0 Marche à pied @5 11
C03 06  X  ENG  @0 Walking @5 11
C03 06  X  SPA  @0 Caminata @5 11
C03 07  X  FRE  @0 Sensibilité @5 12
C03 07  X  ENG  @0 Sensitivity @5 12
C03 07  X  SPA  @0 Sensibilidad @5 12
C07 01  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 01  X  ENG  @0 Cerebral disorder @5 37
C07 01  X  SPA  @0 Encéfalo patología @5 37
C07 02  X  FRE  @0 Pathologie du système nerveux central @5 38
C07 02  X  ENG  @0 Central nervous system disease @5 38
C07 02  X  SPA  @0 Sistema nervosio central patología @5 38
C07 03  X  FRE  @0 Encéphale @5 40
C07 03  X  ENG  @0 Encephalon @5 40
C07 03  X  SPA  @0 Encéfalo @5 40
C07 04  X  FRE  @0 Système nerveux central @5 41
C07 04  X  ENG  @0 Central nervous system @5 41
C07 04  X  SPA  @0 Sistema nervioso central @5 41
C07 05  X  FRE  @0 Locomotion @5 42
C07 05  X  ENG  @0 Locomotion @5 42
C07 05  X  SPA  @0 Locomoción @5 42
C07 06  X  FRE  @0 Trouble neurologique @5 43
C07 06  X  ENG  @0 Neurological disorder @5 43
C07 06  X  SPA  @0 Trastorno neurológico @5 43
N21       @1 291
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 10-0446321 INIST
ET : Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease
AU : MORTON (Susanne M.); TSENG (Ya-Weng); ZACKOWSKI (Kathleen M.); DALINE (Jaclyn R.); BASTIAN (Amy J.)
AF : Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine/Iowa City, Iowa/Etats-Unis (1 aut.); Department of Physical Therapy, Temple University/Philadelphia, Pennsylvania/Etats-Unis (2 aut.); Kennedy Krieger Institute/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Department of Neurology, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Program in Physical Therapy, Washington University School of Medicine/St. Louis, Missouri/Etats-Unis (4 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 12; Pp. 1944-1952; Bibl. 36 ref.
LA : Anglais
EA : Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.
CC : 002B17; 002B17G
FD : Pathologie du cervelet; Ataxie; Pathologie du système nerveux; Pistage; Cervelet; Marche à pied; Sensibilité
FG : Pathologie de l'encéphale; Pathologie du système nerveux central; Encéphale; Système nerveux central; Locomotion; Trouble neurologique
ED : Cerebellar disease; Ataxia; Nervous system diseases; Tracking; Cerebellum; Walking; Sensitivity
EG : Cerebral disorder; Central nervous system disease; Encephalon; Central nervous system; Locomotion; Neurological disorder
SD : Cerebelar enfermedad; Ataxia; Sistema nervioso patología; Rastreo; Cerebelo; Caminata; Sensibilidad
LO : INIST-20953.354000194841700240
ID : 10-0446321

Links to Exploration step

Pascal:10-0446321

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease</title>
<author>
<name sortKey="Morton, Susanne M" sort="Morton, Susanne M" uniqKey="Morton S" first="Susanne M." last="Morton">Susanne M. Morton</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine</s1>
<s2>Iowa City, Iowa</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tseng, Ya Weng" sort="Tseng, Ya Weng" uniqKey="Tseng Y" first="Ya-Weng" last="Tseng">Ya-Weng Tseng</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Physical Therapy, Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zackowski, Kathleen M" sort="Zackowski, Kathleen M" uniqKey="Zackowski K" first="Kathleen M." last="Zackowski">Kathleen M. Zackowski</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Kennedy Krieger Institute</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Daline, Jaclyn R" sort="Daline, Jaclyn R" uniqKey="Daline J" first="Jaclyn R." last="Daline">Jaclyn R. Daline</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Program in Physical Therapy, Washington University School of Medicine</s1>
<s2>St. Louis, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Kennedy Krieger Institute</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0446321</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0446321 INIST</idno>
<idno type="RBID">Pascal:10-0446321</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000912</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease</title>
<author>
<name sortKey="Morton, Susanne M" sort="Morton, Susanne M" uniqKey="Morton S" first="Susanne M." last="Morton">Susanne M. Morton</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine</s1>
<s2>Iowa City, Iowa</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tseng, Ya Weng" sort="Tseng, Ya Weng" uniqKey="Tseng Y" first="Ya-Weng" last="Tseng">Ya-Weng Tseng</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Physical Therapy, Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zackowski, Kathleen M" sort="Zackowski, Kathleen M" uniqKey="Zackowski K" first="Kathleen M." last="Zackowski">Kathleen M. Zackowski</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Kennedy Krieger Institute</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Daline, Jaclyn R" sort="Daline, Jaclyn R" uniqKey="Daline J" first="Jaclyn R." last="Daline">Jaclyn R. Daline</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Program in Physical Therapy, Washington University School of Medicine</s1>
<s2>St. Louis, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bastian, Amy J" sort="Bastian, Amy J" uniqKey="Bastian A" first="Amy J." last="Bastian">Amy J. Bastian</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Kennedy Krieger Institute</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Ataxia</term>
<term>Cerebellar disease</term>
<term>Cerebellum</term>
<term>Nervous system diseases</term>
<term>Sensitivity</term>
<term>Tracking</term>
<term>Walking</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Pathologie du cervelet</term>
<term>Ataxie</term>
<term>Pathologie du système nerveux</term>
<term>Pistage</term>
<term>Cervelet</term>
<term>Marche à pied</term>
<term>Sensibilité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>25</s2>
</fA05>
<fA06>
<s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MORTON (Susanne M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>TSENG (Ya-Weng)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ZACKOWSKI (Kathleen M.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DALINE (Jaclyn R.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BASTIAN (Amy J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine</s1>
<s2>Iowa City, Iowa</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Physical Therapy, Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Kennedy Krieger Institute</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Neurology, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine</s1>
<s2>Baltimore, Maryland</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Program in Physical Therapy, Washington University School of Medicine</s1>
<s2>St. Louis, Missouri</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>1944-1952</s1>
</fA20>
<fA21>
<s1>2010</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000194841700240</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>36 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>10-0446321</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Pathologie du cervelet</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Cerebellar disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Cerebelar enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Ataxie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Ataxia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Ataxia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Pistage</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Tracking</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Rastreo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Cervelet</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Cerebellum</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Cerebelo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Marche à pied</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Walking</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Caminata</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Sensibilité</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Sensitivity</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Sensibilidad</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Encephalon</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Système nerveux central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Central nervous system</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Locomotion</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Locomotion</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Locomoción</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>43</s5>
</fC07>
<fN21>
<s1>291</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 10-0446321 INIST</NO>
<ET>Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease</ET>
<AU>MORTON (Susanne M.); TSENG (Ya-Weng); ZACKOWSKI (Kathleen M.); DALINE (Jaclyn R.); BASTIAN (Amy J.)</AU>
<AF>Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa Carver College of Medicine/Iowa City, Iowa/Etats-Unis (1 aut.); Department of Physical Therapy, Temple University/Philadelphia, Pennsylvania/Etats-Unis (2 aut.); Kennedy Krieger Institute/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Department of Neurology, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine/Baltimore, Maryland/Etats-Unis (3 aut., 5 aut.); Program in Physical Therapy, Washington University School of Medicine/St. Louis, Missouri/Etats-Unis (4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 12; Pp. 1944-1952; Bibl. 36 ref.</SO>
<LA>Anglais</LA>
<EA>Cerebellar damage typically results in ataxia and can be caused by stroke, tumor, or one of many forms of degenerative disease. Since few pharmacological options are available, most treatments rely heavily on rehabilitation therapy. Little data exist on methods for tracking the progression of ataxia, which is critical for assessing the efficacy of current and newly developing treatments. Here, we tracked the severity of ataxia, with a particular emphasis on gait and balance dysfunction, in a group of individuals with cerebellar damage using the International Cooperative Ataxia Rating Scale (ICARS) and several instrumented laboratory measures of gait and balance impairments over 1 year. We found that the ICARS was able to distinguish between subjects with static lesions and those with degenerative disorders, was sensitive to increases in ataxia severity occurring over 1 year, and correlated well with specific instrumented measures of gait in persons with cerebellar degeneration. These results suggest the ICARS is a valuable tool for clinicians and investigators to document and track long-term changes in gait and balance performance in individuals with cerebellar degenerative disorders.</EA>
<CC>002B17; 002B17G</CC>
<FD>Pathologie du cervelet; Ataxie; Pathologie du système nerveux; Pistage; Cervelet; Marche à pied; Sensibilité</FD>
<FG>Pathologie de l'encéphale; Pathologie du système nerveux central; Encéphale; Système nerveux central; Locomotion; Trouble neurologique</FG>
<ED>Cerebellar disease; Ataxia; Nervous system diseases; Tracking; Cerebellum; Walking; Sensitivity</ED>
<EG>Cerebral disorder; Central nervous system disease; Encephalon; Central nervous system; Locomotion; Neurological disorder</EG>
<SD>Cerebelar enfermedad; Ataxia; Sistema nervioso patología; Rastreo; Cerebelo; Caminata; Sensibilidad</SD>
<LO>INIST-20953.354000194841700240</LO>
<ID>10-0446321</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000912 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000912 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0446321
   |texte=   Longitudinal Tracking of Gait and Balance Impairments in Cerebellar Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024